Dr. Imad S Farrukh MD

Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

What is pneumonia?Pneumonia is an acute lung infection that causes inflammation of the air sacs in either one or both lungs. The air sacs get filled with fluid or pus, making it difficult for the affected person to properly breathe. Individuals who have contracted the infection usually cough and...

Tuberculosis, or TB, is a serious bacterial infection that often affects the lungs. It may also spread to other parts of the body, like the central nervous system, lymphatic system, and circulatory system. Treatment for tuberculosis may take a long time. The infectious organism may spread from one...

The Cystic Fibrosis Foundation was founded in 1955 by a group of concerned parents who were determined to save their children’s lives. At the time, very little was known about cystic fibrosis and children with the disease were not expected to live past their elementary school years.However, thanks...

In the United States, there are currently 30,000 individuals living with cystic fibrosis - a progressive, hereditary condition that results in persistent lung infections and airway obstruction, making it difficult to breathe. There is no cure for cystic fibrosis, although there are several treatment...

What is pleurisy?Also known as pleuritis, is a condition that occurs when the pleural membranes lining the lungs and the inner aspect of the chest wall becomes inflamed, which causes them to rub against each other with friction during breathing.Pleurisy makes breathing difficult and painful. It is...